Priorities for Improving the Management of Gastroenteropancreatic ...
This report delineates the main conclusions of the meeting, including the ..... Although the frequency of carcinoid heart disease is as high as 20% at tumor ...
tumor disease, the amount of basic and translational research in this field is
... which are companies that market a somatostatin receptor analog for the ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538549/...
|
William Clifford Roberts, MD: an interview by W. Bruce Fye, MD
Later, my father became interested in heart disease and appears to have had the first ... 1929, just 2 months after the stock market had crashed. ..... he never
made anything on his report card but an A, and his nickname was “Happy. ......
disease associated with the carcinoid syndrome (carcinoid heart disease). ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=19...
|
Roche Annual Report 2008 - Pharmaceuticals
23 Jan 2009 ... Pharma Research. Henry-Vincent Charbonné. Strategic Marketing. Jean-Jacques Garaud. Development. Peter Hug .... surpass heart disease as the leading cause
...... anti-VEGF monoclonal antibody high risk carcinoid ...
http://www.roche.com/gb08e04.pdf...
|
William Clifford Roberts, MD: an interview by W. Bruce Fye, MD
When the market crashed, the value of his investments was es- sentially gone. ..... made anything on his report card but an A, and his nickname was “Happy.
..... in cancer research. In the war he was in the European sector ......
necropsy subjects with carcinoid heart disease to 15 necropsy subjects ...
http://www.baylorhealth.edu/proceedings/20_3/20_3_roberts.pd...
|
Roche Annual Report 2008
surpass heart disease as the leading cause of death worldwide in 2010 and also ...... kits for use in this diverse research market. Its prod- uct portfolio and
capabilities are ...... anti-VEGF monoclonal antibody high risk carcinoid ...
http://www.roche.com/gb08e.pdf...
|
Questions and Answers about Withdrawal of Fenfluramine (Pondimin ...
26 Aug 2009 ... There were also reports of cases of heart valve disease in ... agreed to withdraw the products from the market and FDA has recommended that ...
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInfo...
|
Roche Annual Report 2008 - Pharmaceuticals and Diagnostics pipelines
and inflammatory disease. In June Roche consolidated its leading position in the antiangiogenesis ... tember enables Roche to further advance its research .....
anti-VEGF monoclonal antibody high risk carcinoid .... Second-generation Elecsys
NT proBNP immunoassay for use as an aid in diagnosing heart failure and ...
http://www.roche.com/gb08erd.pdf...
|
ANNUAL REPORT 2007
1 Source: Nicholas Hall, Internal Market Research. 2 2007 Local currency growth vs. prior ...... neuroendocrine and carcinoid tumors, reached annual net sales
.... disease (AVOID) and in reducing the severity of heart failure. (ALOFT). ...
http://www.novartis.com/downloads/investors/reports/NovAR07-...
|
CURRICULUM VITAE Name: David H. Adams, M.D. Address: Department of ...
Partners Cardiovascular Marketing Committee ... Report of Research: Major Research Interests: ...... patients undergoing multivalvular surgery for
carcinoid heart disease: the role of the anaesthetist. Br J Anaesth 2008 Aug 8(
in press). ...
http://www.mountsinai.org/img/vgn_lnk/Regular%20Content/File...
|
Editorials - February 15, 1998 - American Family Physician
The histopathologic features were similar to those seen in carcinoid valvular disease, ... These data were recently summarized in a report from the Centers
for Disease ... Valvular heart disease associated with fenfluramine-phentermine.
... Dr. Gaasch is director of cardiovascular research at the Lahey-Hitchcock ...
http://www.aafp.org/afp/980215ap/edits.html...
|
